SPDR S&P Biotech ETF $XBI Holdings Trimmed by Kingswood Wealth Advisors LLC

Kingswood Wealth Advisors LLC lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.9% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,103 shares of the exchange traded fund’s stock after selling 206 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $423,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of XBI. JPMorgan Chase & Co. boosted its stake in SPDR S&P Biotech ETF by 625.1% during the first quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock valued at $840,983,000 after buying an additional 12,344,558 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in SPDR S&P Biotech ETF by 33.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock worth $1,096,866,000 after buying an additional 3,353,029 shares during the period. Simplex Trading LLC raised its holdings in SPDR S&P Biotech ETF by 116.1% during the 1st quarter. Simplex Trading LLC now owns 241,039 shares of the exchange traded fund’s stock worth $19,548,000 after buying an additional 1,741,445 shares during the period. Migdal Insurance & Financial Holdings Ltd. purchased a new stake in SPDR S&P Biotech ETF during the first quarter valued at about $85,155,000. Finally, Harel Insurance Investments & Financial Services Ltd. purchased a new stake in SPDR S&P Biotech ETF during the first quarter valued at about $48,660,000.

SPDR S&P Biotech ETF Trading Down 1.4%

XBI stock opened at $104.99 on Friday. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $107.26. The firm has a market capitalization of $6.39 billion, a PE ratio of 11.47 and a beta of 0.97. The firm has a 50-day moving average of $93.98 and a two-hundred day moving average of $85.77.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.